18F -FDG |
18F-FDG can detectvarious hematologic neoplasms due to altered glucose consumption. Its half-live is appropriate for clinical use and it is inexpensive tomanufacture reliably
|
Sometimes it is difficult to dis differentiate benign lesions such as inflammation from malignantdisease. And it may not be able to detect malignant involvement in areas of high HueD_Ref18glucose metabolism such as the meninges or the pericardium |
18F-FLT |
18F-FLT PET may reduce the false-positive manifestations due to infection or inflammation, and it may be appropriate for the detection of meningeal diseases because of the negligible background uptake in the brain and skull. |
18F-FLT uptake in bone marrow is unable to demonstrate leukemia infiltration due toit may be caused byboth neoplastic and normal hematopoietic cells |
68Ga-Pentixafor |
68Ga-Pentixafor may possibly be useful for detection, characterization, andtreatment response assessment in CLL patients |
68Ga-Pentixafor reflects the CXCR4 expression, and only used in CXCR4-based CLL |
11C-choline |
The negligible uptake of 11C-Choline in the normal brain may be helpful for the diagnosis of extramedullary AL in brain |
11C-Choline was inappropriate for routine clinical use because of the rapid in vivo degradation and short half-life of 11C |